EPITOPEA LIMITED

Active Cambridge

Research and experimental development on biotechnology

14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EPITOPEA LIMITED

Research and experimental development on biotechnology

Founded 23 Apr 2021 Active Cambridge, United Kingdom 14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Jan 2026 Next due 31 Jan 2027 9 months remaining
Confirmation Submitted 8 May 2025 Next due 6 May 2026 14 days remaining
Net assets £-10M £5M 2025 year on year
Total assets £7M £6M 2025 year on year
Total Liabilities £17M £11M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Salisbury House Station Road Cambridge Cambridgeshire CB1 2LA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EPITOPEA LIMITED (13354764), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 23 Apr 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2022–2025)

Cash in Bank

£4.54M

Increased by £4.14M (+1042%)

Net Assets

-£10.04M

Decreased by £4.84M (-93%)

Total Liabilities

£17.35M

Increased by £10.91M (+169%)

Turnover

£272.26k

Increased by £61.61k (+29%)

Employees

14

Increased by 4 (+40%)

Debt Ratio

237%

Decreased by 285 (-55%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (12)

Investor NameInvestor SinceParticipating Rounds
Investor 2Apr 2022Seed
Investor 3Apr 2022Seed
Investor 4Apr 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 40,461,838 Shares £13.79m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Apr 202533,333£3.333£0
5 Jan 202517,187£1.719£0
23 Oct 20242,608,695£3.00m£1.15
23 Oct 20244,347,826£434.783£0
19 Sept 20246,875£0.688£0.688

Officers

Officers

2 active 1 resigned
Status
Alan RigbyDirectorCanadianUnited States6022 Dec 2023Active
Laurence RulleauDirectorCanadianCanada6130 Nov 2021Active

Shareholders

Shareholders (34)

Cti Life Sciences Fund Iii Lp
15.2%
5,357,065
Fonds De Solidarite Des Travailleurs Du Quebec (f.t.q.)
14.8%
5,217,391

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Jonathan David Moore

Ceased 30 Nov 2021

Ceased

Advent Life Sciences Llp

Ceased 18 Jul 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Feb 2026ResolutionResolutions
29 Jan 2026AccountsAnnual accounts made up to 2025-04-30
28 Jan 2026OfficersAppointment of Mr. Didier Leconte as director on 2026-01-15
28 Jan 2026OfficersAppointment of Mrs. Nadia Di Chiara as director on 2026-01-15
22 Dec 2025OfficersTermination of Maxime Pesant as director on 2025-12-17
5 Feb 2026 Resolution

Resolutions

29 Jan 2026 Accounts

Annual accounts made up to 2025-04-30

28 Jan 2026 Officers

Appointment of Mr. Didier Leconte as director on 2026-01-15

28 Jan 2026 Officers

Appointment of Mrs. Nadia Di Chiara as director on 2026-01-15

22 Dec 2025 Officers

Termination of Maxime Pesant as director on 2025-12-17

Recent Activity

Latest Activity

Resolutions

2 months ago on 5 Feb 2026

Annual accounts made up to 2025-04-30

2 months ago on 29 Jan 2026

Appointment of Mr. Didier Leconte as director on 2026-01-15

2 months ago on 28 Jan 2026

Appointment of Mrs. Nadia Di Chiara as director on 2026-01-15

2 months ago on 28 Jan 2026

Termination of Maxime Pesant as director on 2025-12-17

4 months ago on 22 Dec 2025